BCR triggering leads to the activation of downstream signaling pathways, including the MAPK/ERK, PI3K/AKT/mTOR, and NF-κB pathways, which play a role in CLL survival and proliferation (Figure 2) (5, 29–31). Here, BCR is linked to B-cell chronic lymphocytic leukemia.